Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Leveraging archetypal analysis for classifying glaucomatous visual field defects
Author Affiliations & Notes
  • Collins Opoku-Baah
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Gary C Lee
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Georgin Jacob
    Center for Application Research, Carl Zeiss India Pvt Ltd, Bangalore, Karnataka, India
  • Felipe Medeiros
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Alessandro Jammal
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Niranchana Manivannan
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Footnotes
    Commercial Relationships   Collins Opoku-Baah Carl Zeiss Meditec, Inc., Code E (Employment); Gary Lee Carl Zeiss Meditec, Inc., Code E (Employment); Georgin Jacob Carl Zeiss India Pvt Ltd, Code E (Employment); Felipe Medeiros AbbVie, Annexon, Carl Zeiss Meditec, Inc., Galimedix, Stealth Biotherapeutics; Stuart Therapeutics, Thea Pharmaceuticals, Reichert, Code C (Consultant/Contractor), Google Inc., Heidelberg Engineering, Novartis, Reichert, Code F (Financial Support), nGoggle Inc., Code P (Patent); Alessandro Jammal None; Niranchana Manivannan Carl Zeiss Meditec, Inc., Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1637. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Collins Opoku-Baah, Gary C Lee, Georgin Jacob, Felipe Medeiros, Alessandro Jammal, Niranchana Manivannan; Leveraging archetypal analysis for classifying glaucomatous visual field defects. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1637.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Visual field (VF) interpretation in glaucoma management relies traditionally on subjective assessment which lacks consistency and efficiency. Archetypal Analysis (AA), an unsupervised learning approach, has demonstrated effectiveness in quantifying distinct VF patterns in glaucomatous loss [1]. We explored if using AA as a feature extraction layer could improve deep learning classification of glaucomatous VF defects.

Methods : We applied AA to total deviation (TD) values of 3814 24-2 VFs from 1692 eyes (mean age 63 years, SD=16; average mean deviation -6.5dB, SD=7.5), with augmentation via vertical flipping. AA weights were extracted from a subset of 5612 VFs (90% training, 10% test), including healthy VFs and those marked with one or more common glaucomatous defects (N = 10) by two glaucoma specialists, with an adjudication process for resolving discrepancies. The AA weights were then used as input to a multilayer perceptron (MLP) to classify the different glaucomatous defects in a multilabel format. We compared our AA+MLP model to similar MLP architectures fit to raw TD values (raw+MLP) and weights derived from an AA model using 13231 VFs developed by Elze et al [1] (AAElze+MLP). The MLP models were evaluated using the macro-area under the curve (AUC) metric, applied to the test set.

Results : AA determined 16 distinct archetypes (ATs). Fig 1 shows the top three ATs for two VFs decomposed by our AA model (black) and the AAElze model (red), revealing some similarities in AT patterns despite the models being trained on distinct datasets. We observed superior macro-AUC scores for the AA-based MLP models, 0.906 for AA+MLP and 0.914 for AAElze+MLP compared with 0.889 for the raw+MLP (Fig 2). Notably, raw+MLP exhibited increased variability in its performance across different classes of VF defects, particularly the central and paracentral defects, suggesting the enhanced stability of AA-based MLP models in the classification of glaucomatous VF defects.

Conclusions : AA or other unsupervised approaches may help refine the classification of visual field defects, thereby supporting more consistent and efficient glaucoma management. With a larger dataset, these approaches may improve the performance and reliability of glaucomatous defect classification or optimize the model-building workflow by streamlining the selection of data for annotation from extensive, unlabeled datasets.

[1] Elze et al.J Royal Soc In 2015; 12(103)

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×